Summary from the Kidney Cancer Association’s inaugural think thank: Coalition for a cure
Authors list
Brian Rini E Jason Abel Laurence Albiges Axel Bex James Brugarolas Ronald M Bukowski Jonathan A Coleman Charles G Drake Robert A Figlin Andy Futreal Hans Hammers Thomas Powles W Kimryn Rathmell Christopher J Ricketts Samra Turajlic Christopher G Wood Bradley C LeibovichAbstract
Close to 74,000 cases of renal cell carcinoma (RCC) are diagnosed each year in the United States. The past 2 decades have shown great developments in surgical techniques, targeted therapy and immunotherapy agents, and longer complete response rates. However, without a global cure, there is still room for further advancement in improving patient care in this space. To address some of the gaps restricting this progress, the Kidney Cancer Association brought together a group of 27 specialists across the areas of clinical care, research, industry, and advocacy at the inaugural "Think Tank: Coalition for a Cure" session. Topics addressed included screening, imaging, rarer RCC subtypes, combination drug therapy options, and patient response. This commentary summarizes the discussion of these topics and their respective clinical challenges, along with a proposal of projects for collaboration in overcoming those needs and making a greater impact on care for patients with RCC moving forward.
Journal details
Journal Clinical Genitourinary Cancer
Volume 19
Issue number 2
Pages 167-175
Available online
Publication date
Full text links
Publisher website (DOI) 10.1016/j.clgc.2020.10.005
Europe PubMed Central 33358149
Pubmed 33358149
Keywords
Type of publication